Recurrent Ovarian Germ Cell Tumor: Clinical Trials

29 trials for Recurrent Ovarian Germ Cell Tumor, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

20 completed, 6 terminated, 3 withdrawn. 11 Phase 1, 10 Phase 2, 7 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 111Completed 8, Terminated 2, Withdrawn 1
Phase 210Completed 7, Terminated 3
Not applicable7Completed 4, Withdrawn 2, Terminated 1

Follow Recurrent Ovarian Germ Cell Tumor: new trials by email Literature Review of Recurrent Ovarian Germ Cell Tumor trials Research Report on Recurrent Ovarian Germ Cell Tumor

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Metformin and Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
metformin hydrochloride, placebo, Chemotherapy - Brenner Tumor, Malignant Ascites
Phase 2CompletedUniversity of Chicago1112015-02-252026-03-27
Palliative Care in Improving Quality of Life and Symptoms in Patients With Stage III-IV Pancreatic or Ovarian Cancer
palliative care, educational intervention, quality-of-life assessment - Recurrent Ovarian Epithelial Cancer, Recurrent Ovarian Germ Cell Tumor
Not applicableWithdrawnCity of Hope Medical Center2014-12-012014-12-23
Everolimus and Letrozole in Treating Patients With Recurrent Hormone Receptor Positive Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer
Everolimus, Laboratory Biomarker Analysis, Letrozole - Ovarian Endometrioid Adenocarcinoma, Ovarian Seromucinous Carcinoma
Phase 2CompletedMayo Clinic202014-11-142020-10-23
Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung Cancers
educational intervention, telephone-based intervention, quality-of-life assessment - Healthy Subject, Localized Transitional Cell Cancer of the Renal Pelvis and Ureter
Not applicableCompletedCity of Hope Medical Center2002013-10-292026-10-01
Palifosfamide in Treating Patients With Recurrent Germ Cell Tumors
palifosfamide - Adult Central Nervous System Germ Cell Tumor, Adult Teratoma
Phase 2TerminatedIndiana University52013-02-012015-07-02
Mechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem Cell Transplant
management of therapy complications, musculoskeletal complications management/prevention - Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission
Not applicableWithdrawnRoswell Park Cancer Institute2012-05-012012-07-09
Carboplatin, Gemcitabine Hydrochloride, and Stereotactic Body Radiation Therapy in Gynecological Cancer
stereotactic body radiation therapy, carboplatin, gemcitabine hydrochloride - Leydig Cell Tumor, Ovarian Sarcoma
Phase 1CompletedCase Comprehensive Cancer Center122012-05-012015-08-04
Phase I Stereotactic Body Radiation for Metastatic or Recurrent Platinum-Resistant Ovarian Cancer
stereotactic body radiation therapy, positron emission tomography, computed tomography - Recurrent Ovarian Epithelial Cancer, Recurrent Ovarian Germ Cell Tumor
Phase 1TerminatedStanford University12012-04-012017-04-28
Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid Tumors
veliparib, capecitabine, oxaliplatin - Adenocarcinoma of the Pancreas, Adenocarcinoma of the Stomach
Phase 1TerminatedNational Cancer Institute (NCI)162010-10-012014-04-02
Stress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast Cancer
questionnaire administration, quality-of-life assessment, psychosocial assessment and care - Anxiety Disorder, Depression
Not applicableCompletedOhio State University Comprehensive Cancer Center392010-10-012015-10-09
Deferasirox for Treating Patients Who Have Undergone Allogeneic Stem Cell Transplant and Have Iron Overload
deferasirox - Iron Overload, Accelerated Phase Chronic Myelogenous Leukemia
Phase 2TerminatedCity of Hope Medical Center12010-07-012019-06-18
Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors
temsirolimus, vinorelbine ditartrate - Extensive Stage Small Cell Lung Cancer, Hereditary Paraganglioma
Phase 1CompletedUniversity of Southern California192010-06-012016-06-13
Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid Tumors
Gamma-Secretase Inhibitor RO4929097, Cediranib Maleate, Pharmacological Study - Adult Anaplastic Astrocytoma, Adult Anaplastic Ependymoma
Phase 1CompletedNational Cancer Institute (NCI)202010-05-012014-12-23
Quality of Life and Survivorship Care in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
HIPEC Orientation, Consultation with Survivorship Navigator, Questionnaires - Advanced Malignant Mesothelioma, Carcinoma of the Appendix
Not applicableCompletedWake Forest University Health Sciences102010-05-012018-07-03
Phase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With Cancer
PD-0332991 - Adult Solid Tumor, Adenocarcinoma of the Colon
Phase 2CompletedAbramson Cancer Center at Penn Medicine3042009-10-012021-03-11
Alvocidib and Oxaliplatin With or Without Fluorouracil and Leucovorin Calcium in Treating Patients With Relapsed or Refractory Germ Cell Tumors
Alvocidib Hydrochloride, Fluorouracil, Leucovorin Calcium - Recurrent Extragonadal Seminoma, Recurrent Malignant Extragonadal Germ Cell Tumor
Phase 2CompletedNational Cancer Institute (NCI)362009-06-012017-03-10
Stereotactic Radiosurgery Using CyberKnife in Treating Women With Advanced or Recurrent Gynecological Malignancies
stereotactic radiosurgery, quality-of-life assessment - Fallopian Tube Cancer, Ovarian Sarcoma
Phase 2CompletedCase Comprehensive Cancer Center502009-05-012013-11-28
Ondansetron in Preventing Nausea and Vomiting in Patients Undergoing Stem Cell Transplant
ondansetron, survey administration, management of therapy complications - Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission
Phase 2CompletedFred Hutchinson Cancer Center492008-08-082017-05-23
Combination Chemotherapy in Treating Young Patients With Recurrent or Resistant Malignant Germ Cell Tumors
Carboplatin, Filgrastim, Ifosfamide - Childhood Extracranial Germ Cell Tumor, Childhood Extragonadal Malignant Germ Cell Tumor
Phase 2CompletedChildren's Oncology Group202007-11-052018-08-29
Busulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid Tumor
busulfan, melphalan, topotecan hydrochloride - Solid Tumor, Adult Central Nervous System Germ Cell Tumor
Phase 1CompletedCity of Hope Medical Center252007-02-262025-03-20

Showing 20 of 29. Sign in to see all of them.

Narrower conditions

Carcinoma, Ovarian Epithelial (20)  ·  Breast Neoplasms (12)  ·  Testicular Neoplasms (11)  ·  Fallopian Tube Neoplasms (8)  ·  Colonic Neoplasms (7)  ·  Uterine Cervical Neoplasms (7)  ·  Endometrial Neoplasms (6)  ·  Neuroblastoma (6)  ·  Pancreatic Neoplasms (6)  ·  Rectal Neoplasms (6)  ·  Burkitt Lymphoma (5)  ·  Carcinoma, Non-Small-Cell Lung (5)  ·  Congenital Abnormalities (5)  ·  Hodgkin Disease (5)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (5)

Broader conditions

Endocrine Gland Neoplasms (29)  ·  Endocrine System Diseases (29)  ·  Genital Diseases (29)  ·  Gonadal Disorders (29)  ·  Neoplasms by Site (29)  ·  Urogenital Diseases (29)  ·  Urogenital Neoplasms (29)  ·  Neoplasms (28)  ·  Neoplasms by Histologic Type (27)  ·  Female Urogenital Diseases (24)  ·  Female Urogenital Diseases and Pregnancy Complications (24)  ·  Adnexal Diseases (23)  ·  Genital Diseases, Female (23)  ·  Genital Neoplasms, Female (23)  ·  Neoplasms, Glandular and Epithelial (23)

Interventions

Carboplatin (4)  ·  Early Intervention, Educational (3)  ·  Methods (3)  ·  Paclitaxel (3)  ·  Radiosurgery (3)  ·  Taxes (3)  ·  Filgrastim (2)  ·  Granulocyte Colony-Stimulating Factor (2)  ·  Ifosfamide (2)  ·  Metformin (2)  ·  Oxaliplatin (2)  ·  Sirolimus (2)  ·  temsirolimus (2)  ·  2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide (1)  ·  2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole (1)

Sponsors

National Cancer Institute (NCI) (8)  ·  City of Hope Medical Center (4)  ·  Case Comprehensive Cancer Center (2)  ·  Fred Hutchinson Cancer Center (2)  ·  Abramson Cancer Center at Penn Medicine (1)  ·  Children's Oncology Group (1)  ·  Fox Chase Cancer Center (1)  ·  Gynecologic Oncology Group (1)  ·  Indiana University (1)  ·  Mayo Clinic (1)  ·  Ohio State University Comprehensive Cancer Center (1)  ·  Roswell Park Cancer Institute (1)  ·  Stanford University (1)  ·  University of Chicago (1)  ·  University of Southern California (1)

Countries

United States (26)  ·  Canada (3)  ·  Australia (1)  ·  Puerto Rico (1)

Top investigators

Agustin Garcia (1)  ·  Amit Oza (1)  ·  Angela Jain (1)  ·  Anna Pawlowska, MD (1)  ·  Barbara Andersen, PhD (1)  ·  Betty Ferrell (1)  ·  Carlos Rodriguez-Galindo (1)  ·  Christopher Ryan (1)  ·  Darren Feldman (1)  ·  Elizabeth Kidd (1)  ·  Ewa Carrier (1)  ·  Gerardo Colon-Otero (1)  ·  Lawrence H Einhorn, MD (1)  ·  Leona Holmberg (1)  ·  Mary Disis (1)

Results publications

PMID 18974373, PMID 28817727, PMID 32641862, PMID 32692450

NIH funding

U01CA062491 (2), N01CM00071 (1), N01CM62206 (1), P01CA087971 (1), P30CA006927 (1), P30CA008748 (1), P30CA014520 (1), P30CA015083 (1), P30CA033572 (1), P30CA044579 (1), R01CA093891 (1), R21CA135005 (1), U01CA062505 (1), U01CA069856 (1), U01CA069912 (1)